Express Scripts will limit opioids
ST. LOUIS — The largest U.S. pharmacy benefit manager will soon limit opioid drugs for firsttime users as part f a wide-ranging effort to curb an epidemic.
But the new program from Express Scripts is drawing criticism from the American Medical Association, the largest association of physicians and medical students in the U.S., which believes treatment plans should be left to doctors and patients.
About 12.5 million Americans misused prescription opioids in 2015, according to the U.S. Department of Health and Human Services. More than 33,000 deaths that year were blamed on opioid overdoses.
Express Scripts started a yearlong pilot program in 2016 to reduce patients’ dependency on opioids and the risk of addiction, said Snezana Mahon, the company’s vice president of clinical product development.
Mahon said analysis of 106,000 patients in the program showed a 38 percent reduction in hospitalizations and a 40 percent drop in emergency room visits, compared with a control group. The program is scheduled to take effect nationwide on Sept. 1 for Express Scripts members whose employer or health insurer has enrolled to participate.
Under the program, new users are limited to seven-day prescriptions, even if the doctor orders scripts for much longer. Mahon said the average prescription is for 22 days.
The program also requires short-acting drugs for first-time prescriptions, even though many doctors prescribe long-acting opioids. Dosage is also limited, and the company will monitor and try to prevent for patterns of potential “pill shopping,” where a patient goes from doctor to doctor to collect prescriptions.
The program does not apply to patients in hospice or palliative care, or to cancer patients.
CVS Caremark has a similar program.
“A lot of times physicians are prescribing these drugs blindly,” Mahon said. “They don’t know that a patient may be going to see multiple prescribers.”
She said some physicians “are actually appreciative and saying, ‘Thank you, I didn’t know this was happening.’ ”
But Dr. Patrice Harris, an Atlanta psychiatrist who chairs the AMA’s Opioids Task Force, said doctors are already working to address the opioid epidemic.
Harris said doctors have reduced such prescriptions by 17 percent over the past couple of years and are directing patients to other forms of pain management, including physical therapy and cognitive behavioral therapy.
“We want to be proactive in making sure the alternatives are available, versus a sort of blunt, one-size-fits-all approach regarding the number of prescriptions,” Harris said. “The AMA’s take has always been that the decision about a specific treatment alternative is best left to the physician and their patient.”
Express Scripts said that if a doctor wants a patient to have more than a seven-day supply of medication, he or she can request it. Harris said those additional steps create an administrative burden for the doctor, “but more importantly they delay care for the patient.”
Harris said the AMA has not contacted Express Scripts to raise concerns about the program.